Medicine News and Research

RSS

Montana Gov. seeks cheaper drugs for residents; Legal immigrants may lose health insurace in Mass.

The Associated Press: "Gov. Brian Schweitzer, cooking up a new plan to get cheaper prescription drugs for state residents, said he wants to let every Montanan get discounted medicine through Medicaid." It's his most recent idea about how "to either import cheaper name-brand prescriptions or to otherwise bypass what he sees as exorbitant prices charged by 'drug cartels.'"

27 Aug 2010

Fosun Pharma increases investment in Chindex

Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, and Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a leading manufacturer and distributor of western and Chinese medicine and devices in China, today announced that they have consummated a previously-announced stock sale.

27 Aug 2010

Transcatheter heart valve replacement recipient celebrates 102nd birthday

When Doris Snyder celebrated her 102nd birthday on August 10, she was that much closer to the expected birth of her first great-granddaughter who's due to arrive early September. She is very excited about the milestone, which might not have been possible were it not for a cutting-edge, experimental procedure that replaced one of Doris' heart valves weeks earlier when she was 101. The valve had been rendered useless by aortic valve stenosis—hardening from calcium deposits that restrict the flow of blood from the heart.

27 Aug 2010

Research Roundups: Underinsured children; Hospital progress on electronic records; Federal officlals' work on comparative effectiveness

Underinsurance Among Children In The United States - This study examines the scope of underinsurance, or health insurance that fails to sufficiently meet the needs, of children living in the U.S. Based on information obtained from the 2007 National Survey of Children's Health, the authors of the study report, "19.3% — or 14.1 million — of all U.S. children (and 22.7% of children with continuous insurance coverage) were underinsured in 2007, exceeding the number of children without any insurance at all during the year (3.4 million) and the number who had insurance during only part of the year (7.6 million)."

27 Aug 2010

FDA approves Novartis' Tekamlo for treatment of high blood pressure

The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used calcium channel blocker amlodipine. Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals, and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone.

27 Aug 2010

Elsevier, KIT sign MoU to provide developing country researchers access to ScienceDirect and Scopus

Elsevier and the Royal Tropical Institute (KIT) in Amsterdam announced on 26th of August the signing of a Memorandum of Understanding (MoU) providing 150 researchers working in least-developed and low-income countries (for example Benin, Mozambique, Ethiopia, Togo etc.) with access to ScienceDirect and Scopus, Elsevier's online scientific research platform and flagship abstract and citation database.

27 Aug 2010

APF offers actionable solutions to improve access to pain care

The American Pain Foundation (APF), the nation's largest consumer advocacy organization for people in pain, released today a position statement imploring the medical community, regulators and concerned stakeholders to reaffirm their ethical commitment to the 76.5 million Americans—or one in four people—who struggle with pain, work collaboratively to improve access to pain care and dismantle the barriers preventing timely, appropriate and effective pain care for millions.

27 Aug 2010

First Edition: August 27, 2010

In the headlines today, news about U.S. plans to step up efforts to crack down on health care fraud.

27 Aug 2010

Viking Systems to present Next Generation 3DHD technology at 5th ISHAC

Viking Systems, Inc. announced today that it will present its Next Generation 3DHD technology at the 5th International Symposium on Hybrid Approach to Congenital Heart Disease (ISHAC) from August 31 - September 2, 2010 in Columbus, Ohio.

27 Aug 2010

Genentech receives FDA Refuse to File letter for accelerated approval of trastuzumab-DM1 BLA

ImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that Genentech, a member of the Roche Group, today announced its receipt of a Refuse to File (RTF) letter from the US Food and Drug Administration (FDA) for the accelerated approval of the Biologic License Application (BLA) for trastuzumab-DM1, or T-DM1, submitted in July 2010.

27 Aug 2010

'Molecular Diagnostics Europe' conference debuts at BIOTECHNICA 2010

BIOTECHNICA, Europe's Leading Exhibition for Biotechnology and Life Sciences, is broadening its portfolio to include a new conference and special display on molecular diagnostics. Produced by the Cambridge Healthtech Institute, a leading organizer of biomedical conferences in the United States, the "Molecular Diagnostics Europe" (MDxEU) conference is making its debut this year. The main focus will be on new methods for molecular diagnostics, particularly with regard to cancer and infectious diseases.

27 Aug 2010

'Neural inertia' may explain brain's resistance to changes in consciousness

Despite the fact that an estimated 25 million patients per year in the U.S. undergo surgeries using general anesthesia, scientists have only been able to hypothesize exactly how anesthetics interact with the central nervous system. They previously thought that the processes of "going under" and waking up from anesthesia affected the brain in the same way.

27 Aug 2010

New system safely induces sensory, mobility disturbances experienced by astronauts after return to Earth

What does it feel like to return to Earth after a long stay in space? Until now, it has been difficult during astronaut training to realistically simulate the dizzying effects the human body can experience.

27 Aug 2010

Shire receives European marketing approval for VPRIV therapy to treat type 1 Gaucher disease

Shire, the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of type 1 Gaucher disease.

27 Aug 2010

MCNA announces $2 million to launch HEAL program for childhood asthma management

The mold that spread like a rash across post-Katrina New Orleans did more than destroy homes - it made children with asthma sick. On the fifth anniversary of Hurricane Katrina, experts point to increased sensitivities to environmental asthma triggers as a risk for more severe asthma symptoms and attacks in hundreds of New Orleans children.

27 Aug 2010

QE Brushes announces name change to Virtual Medical International

QE Brushes, a Nevada corporation, has applied for a name change to become Virtual Medical International. Virtual Medical International aims to be a leader in the field of Telemedicine.

27 Aug 2010

Increase in regeneration of nerve cells can alleviate or prevent memory loss

Production of new nerve cells in the human brain is linked to learning and memory, according to a new study from the University of Florida. The research is the first to show such a link in humans. The findings, published online and in an upcoming print issue of the journal Brain, provide clues about processes involved in age- and health-related memory loss and reveal potential cellular targets for drug therapy.

27 Aug 2010

New York State permits Genelex Corporation's DNA Drug Sensitivity Tests

The New York State Department of Health has licensed Genelex Corporation's DNA Drug Sensitivity Tests for use by doctors in the state. The issued Clinical Laboratory Permit is for DNA testing of three enzymes, the cytochrome P450s, that process more than 50 percent of the most commonly prescribed medicines.

27 Aug 2010

Study: One in four kids underinsured before recession

Even prior to the onset of the economic recession in 2008, nearly one in four American parents with health insurance reported that their coverage was so inadequate they were unable to access the medical care their children needed.

27 Aug 2010

Experimental drug PLX4032 holds promise against cancers with faulty BRAF gene

An experimental drug designed to treat cancers with a particular genetic fault has shown promising results in a small clinical trial.

27 Aug 2010

Medicine News and Research

Montana Gov. seeks cheaper drugs for residents; Legal immigrants may lose health insurace in Mass.

Fosun Pharma increases investment in Chindex

Transcatheter heart valve replacement recipient celebrates 102nd birthday

Research Roundups: Underinsured children; Hospital progress on electronic records; Federal officlals' work on comparative effectiveness

FDA approves Novartis' Tekamlo for treatment of high blood pressure

Elsevier, KIT sign MoU to provide developing country researchers access to ScienceDirect and Scopus

APF offers actionable solutions to improve access to pain care

First Edition: August 27, 2010

Viking Systems to present Next Generation 3DHD technology at 5th ISHAC

Genentech receives FDA Refuse to File letter for accelerated approval of trastuzumab-DM1 BLA

'Molecular Diagnostics Europe' conference debuts at BIOTECHNICA 2010

'Neural inertia' may explain brain's resistance to changes in consciousness

New system safely induces sensory, mobility disturbances experienced by astronauts after return to Earth

Shire receives European marketing approval for VPRIV therapy to treat type 1 Gaucher disease

MCNA announces $2 million to launch HEAL program for childhood asthma management

QE Brushes announces name change to Virtual Medical International

Increase in regeneration of nerve cells can alleviate or prevent memory loss

New York State permits Genelex Corporation's DNA Drug Sensitivity Tests

Study: One in four kids underinsured before recession

Experimental drug PLX4032 holds promise against cancers with faulty BRAF gene

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News